2-es típusú cukorbetegség: vizsgálatok itt: Magyarország
19 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in MagyarországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Balatonfüred, Budapest XII, Budapest XVII, Debrecen, Nagykanizsa, Nyíregyháza, Szeged
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Baja, Békéscsaba, Budapest, Budapest VI, Budapest Viii, Budapest XIII, Budapest XVIII, Hatvan, Kaposvár, Komárom, Pécs, Szekszárd
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 2. fázisFut, nem toborozA Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Where
- Budapest, Budapest III, Debrecen, Nyíregyháza, Szeged, Szolnok
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07112872 · EU 2024-520322-11-00 - 3. fázisTaking peopleAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Baja, Balatonfüred, Békéscsaba, Gyula, Kaposvár, Kecskemét, Nyíregyháza, Szeged
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - 3. fázisTaking peopleA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Biatorbágy, Budapest XIII, Budapest XXI, Pécs, Szolnok
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - 3. fázisFut, nem toborozA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Balatonfüred, Budapest XII, Budapest XIII, Budapest XXI, Debrecen, Szeged, Szekesfehervar
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisVisszavonvaA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Balatonfüred, Budapest VIII, Budapest XII, Budapest XIII, Debrecen, Szeged
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisNot yet taking people in MagyarországA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Budapest, Budapest XII, Debrecen, Nyíregyháza, Szeged
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - 3. fázisNot yet taking people in MagyarországA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Budapest III, Budapest VIII, Budapest XIII, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisVisszavonvaA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Balatonfüred, Budapest, Debrecen, Miskolc, Nyíregyháza-Sóstóhegy, Szeged, Szolnok
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Budapest III, Budapest VIII, Budapest XIII, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Budapest III, Budapest VIII, Budapest X, Pécs, Szeged
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - 3. fázisFut, nem toborozA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Baja, Bekescsaba, Békéscsaba, Biatorbágy, Budapest III, Budapest VIII, Budapest XIV, Nyíregyháza, Szeged, Szolnok
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 2. fázisVisszavonvaA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Debrecen, Szeged
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - 3. fázisNot yet taking people in MagyarországA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Budapest, Debrecen, Dunaújváros, Szeged, Szolnok
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00 - No phaseTaking peopleA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Where
- Budapest, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Életkor
- 18 év and over
- People
- 2150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07606066 - No phaseTaking peopleHealth for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
- Where
- Balatonfüred, Békéscsaba, Budapest, Csorna, Debrecen, Encs, Győr, Gyula, Hatvan, Jászszentlászló, Kaposvár, Kecskemét, Miskolc, Nyíregyháza, Orosháza, Pécs, Sopron, Szeged, Székesfehérvár
- Életkor
- 40 év and over
- People
- 15 000
- Run by
- Center for Molecular Fingerprinting Research Nonprofit LLC
See details and how to joinNCT07743021 - No phaseNot yet taking people in MagyarországInvestigation of the Effectiveness of Prophylactic NPWT (ciNPWT) in High-risk Diabetic Patients With Acute Laparotomy Wounds
- Where
- Budapest
- People
- 110
- Run by
- Semmelweis University
See details and how to joinNCT07392853 - No phaseTaking peopleCardiovascular Risk in Children With Chronic Conditions Study
- Where
- Budapest
- Életkor
- 6 év to 25 év
- People
- 300
- Run by
- Semmelweis University
See details and how to joinNCT07086989